Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLARITHROMYCIN Cause Urinary tract infection? 113 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Urinary tract infection have been filed in association with CLARITHROMYCIN (Clarithromycin). This represents 0.6% of all adverse event reports for CLARITHROMYCIN.

113
Reports of Urinary tract infection with CLARITHROMYCIN
0.6%
of all CLARITHROMYCIN reports
14
Deaths
91
Hospitalizations

How Dangerous Is Urinary tract infection From CLARITHROMYCIN?

Of the 113 reports, 14 (12.4%) resulted in death, 91 (80.5%) required hospitalization, and 1 (0.9%) were considered life-threatening.

Is Urinary tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLARITHROMYCIN. However, 113 reports have been filed with the FAERS database.

What Other Side Effects Does CLARITHROMYCIN Cause?

Drug ineffective (2,012) Nausea (1,597) Drug hypersensitivity (1,558) Drug interaction (1,288) Diarrhoea (1,228) Dyspnoea (1,151) Malaise (1,131) Headache (1,047) Off label use (944) Vomiting (921)

What Other Drugs Cause Urinary tract infection?

ADALIMUMAB (6,375) LENALIDOMIDE (4,247) ETANERCEPT (3,915) OCRELIZUMAB (3,618) TOFACITINIB (3,179) METHOTREXATE (2,960) DALFAMPRIDINE (2,757) RITUXIMAB (2,579) CARBIDOPA\LEVODOPA (2,151) ABATACEPT (2,110)

Which CLARITHROMYCIN Alternatives Have Lower Urinary tract infection Risk?

CLARITHROMYCIN vs CLARITIN CLARITHROMYCIN vs CLARITIN CHEWABLE CLARITHROMYCIN vs CLARITIN-D-12 CLARITHROMYCIN vs CLARITIN-D-24 CLARITHROMYCIN vs CLARITIN REDITABS

Related Pages

CLARITHROMYCIN Full Profile All Urinary tract infection Reports All Drugs Causing Urinary tract infection CLARITHROMYCIN Demographics